Home >
Medicine Info >
Aravon 1.5 mg Injection
Loading interface...

Aravon 1.5 mg Injection

Manufactured bySun Pharma Laboratories Ltd.
ContainsEdaravone
Description
Aravon 1.5 mg Injection is used in the treatment of Amyotrophic Lateral Sclerosis (ALS), a nerve disorder which weakens and shrinks the muscles due to the slow destruction of nerve cells controlling muscle movements. This medicine slows the progression of the disease and does not cure the disease or improves the muscle movements.
QUICK LINKS:
Side effectsConcernsUsage

Substitutes

List of substitutes for Aravon 1.5 mg Injection

Edakem 1.5 mg Injection
Alkem Laboratories Ltd.
Edarabid 1.5 mg Injection
Intas Pharmaceuticals Ltd.
Edavit 1.5 mg Injection
Micro Labs Ltd.
Ezycut 1.5 mg Injection
Zydus Cadila
Fraseda 1.5 mg Injection
Dr. Reddys Laboratories Ltd.

Side effects

Major & minor side effects for Aravon 1.5 mg Injection

  • Hypersensitivity
  • Easy bruising and bleeding
  • Gait disturbance
  • Headache
  • Respiratory failure/hypoxia
  • Decrease in blood cell count
  • Increased liver enzyme levels
  • Kidney Impairment
  • Nausea and vomiting

Uses of Aravon 1.5 mg Injection

What is it prescribed for?

  • Amyotrophic lateral scelrosis (ALS)
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before using this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. The risks and benefits should be discussed with the doctor before using this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to edaravone or any other inactive ingredients present along with it.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. The risks and benefits should be discussed with the doctor before using this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. The risks and benefits should be discussed with the doctor before using this medicine.
General warnings

Route of administration

Aravon 1.5 mg Injection should be administered as an intravenous infusion only.

Use in geriatrics

Extreme caution is advised while using Aravon 1.5 mg Injection in elderly patients due to the increased risk of life-threatening adverse effects.

Use in pediatrics

This medicine is not recommended for use in children and adolescents.

Renal impairment

Aravon 1.5 mg Injection should be used with extreme caution in patients with impaired kidney function due to the increased risk of kidney failure.

Missed Dose

If you miss an appointment for a dose of Aravon 1.5 mg Injection, contact your doctor immediately and schedule the dose as soon as possible.

Overdose

Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Antibiotics

Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
This medicine is usually administered by a qualified healthcare professional. Follow all the instructions given by your doctor and do not miss an appointment to receive this medicine. Consult your doctor if you experience any undesirable effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Aravon 1.5 mg Injection works by slowing the destruction of nerve cells, thereby slowing the progression of the disease and worsening of the patient's condition.
Legal Status

Approved

Approved

Unknown

Approved

Classification

Category

Antioxidants, Free radical scavengers

Schedule

N/A

Edaravone Injection: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 19 August 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a617027.html

DailyMed - RADICAVA- edaravone injection [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 19 August 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0ce2c1c4-2a40-485c-b7cb-96a9b85d9d11&audience=consumer

Edaravone - DrugBank [Internet]. Drugbank.ca. 2017 [cited 19 August 2017]. Available from:

https://www.drugbank.ca/drugs/DB12243

[Internet]. Genome.jp. 2017 [cited 19 August 2017]. Available from:

http://www.genome.jp/dbget-bin/www_bfind_sub?mode=bfind&max_hit=1000&dbkey=all&keywords=edaravone

[Internet]. 2017 [cited 19 August 2017]. Available from:

http://www.e-search.ne.jp/~jpr/PDF/MT18.PDF
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 29 Aug 2017

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.